Le Lézard
Classified in: Health
Subject: PER

Hansa Medical Announces Appointment of Anne Säfström Lanner as Vice President, Global Human Resources


LUND, Sweden, Jan. 18, 2019 /PRNewswire/ -- Hansa Medical AB (NASDAQ Stockholm: HNSA), the leading biopharma company focusing on inhibition of immunoglobulin G (IgG)-mediated immunopathologies, today announced the appointment of Anne Säfström Lanner as Vice President, Global Human Resources.

Mrs. Lanner has over 15 years of broad human resources experience in international growth companies, including developing and implementing strategies for talent acquisition and management, organizational culture and employer branding, compensation and benefits, and employee training and development. Prior to joining Hansa, she served at European Spallation Source (ESS), a European multi-disciplinary research facility, in HR leadership roles of increasing responsibility, most recently as Head of Resourcing. Previously, Mrs. Lanner was Head of Human Resources at CellaVision, a provider of digital solutions for medical microscopy within hematology. She earned her Bachelor of Social Science in Human Resource Management, with a focus in organizational development & leadership, at Lund University.

"We are delighted to welcome Anne as we grow Hansa Medical into a global commercial-stage biopharma company. Anne is very experienced in developing strategic human resources programs aligned with business objectives and will work with management to help maximize Hansa's organizational productivity and secure our position as an employer of choice," said Søren Tulstrup, President & CEO of Hansa Medical.

The information was submitted for publication, through the agency of the contact person set out below at 08:00am CET on January 18, 2019. 

For further information, please contact:

Company:

Emanuel Björne
Vice President Business Development and Investor Relations
Hansa Medical AB (publ)
Mobile: +46-707-175477
E-mail: [email protected]

Swedish Investor and Media Relations:

Cord Communications
Mikael Widell
+46-70-311-99-60

U.K. Investor and Media Relations

FTI Consulting
Simon Conway/ Stephanie Cuthbert 
+44(0)20-3727-1000

U.S. Investor and Media Relations:

Argot Partners
Stephanie Marks/ David Rosen (media)
+1-212-600-1902

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/hansa-medical/r/hansa-medical-announces-appointment-of-anne-safstrom-lanner-as-vice-president--global-human-resource,c2720933

The following files are available for download:

https://mb.cision.com/Main/1219/2720933/978528.pdf

Hansa Medical Announces Appointment of Anne Säfström Lanner as Vice President, Global Human Resources

SOURCE Hansa Medical


These press releases may also interest you

at 16:54
Hondros College of Nursing (HCN) will introduce a new Medical Assisting program at its six Ohio campuses in 2024 to meet the growing need for medical assistants in a variety of settings.  According to the U.S. Bureau of Labor Statistics (BLS),...

at 16:45
Halozyme Therapeutics, Inc. ("Halozyme") today announced the election of Mahesh Krishnan, M.D. to its Board of Directors. Dr. Krishnan has more than 20 years of experience in healthcare, biotechnology and health services. "Mahesh is a dynamic and...

at 16:35
Geron Corporation , a late-stage clinical biopharmaceutical company, today announced that it will release its first quarter 2024 financial results and business highlights before the market opens on Thursday, May 2, 2024 via press release, which will...

at 16:35
Tilray Brands, Inc. , a leader in the craft beer and cannabis-lifestyle industries, celebrates high honors and awards at the 2024 Craft Brewer's Conference and World Beer Cup. 10 Barrel Brewing won four craft beer awards and 10...

at 16:34
Fusion Pharmaceuticals Inc. , a clinical-stage oncology company focused on developing next-generation radioconjucates (RCs) as precision medicines, today announced that it has filed and is in the process of mailing the management information circular...

at 16:30
In an important step toward driving long-term affordability and access to treatments for chronic and complex conditions, Evernorth Health Services announced that it will have a Humira® biosimilar available for $0 out of pocket for eligible...



News published on and distributed by: